+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hyaluronic Acid-Based Dermal Fillers Market (2022-2027) by Product, Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 180 Pages
  • October 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5684545
UP TO OFF until Dec 31st 2023

Quick Summary:

In the rapidly evolving landscape of the Global Hyaluronic Acid-Based Dermal Fillers Market, gaining actionable insights is essential for making strategic decisions that drive success. This comprehensive market research report delivers an in-depth understanding of the market's underlying dynamics, stakeholder behaviors, segmentation by product, application, and geography, and the competitive landscape.

Beyond these granular insights, the report offers a well-rounded view of the key forces shaping the Hyaluronic Acid-Based Dermal Fillers market. Drawing from macro and micro-economic factors, it delves into aspects beyond price, demand, and supply, even factoring in the human emotions that can impact market decisions. Furthermore, the report analyses strategies employed by companies like AbbVie Inc., Galderma Laboratories L.P., and Genzyme Corp. among others, providing a bird's eye view of the competitive scenario.

Armed with these analytical tools and insights, including a detailed Ansoff matrix analysis and the proprietary Competitive Quadrant tool, decision-makers can devise effective growth strategies, mitigate risks, and bolster their market positions. This analytical depth makes this report an invaluable reference for senior executives looking to harness the potential of the Global Hyaluronic Acid-Based Dermal Fillers Market.

Rha® Collection Represents the Latest Advancement in Hyaluronic Acid (Ha) Technology, Using a Gentle Manufacturing Process to More Closely Resemble the Natural Ha in the Skin

The Global Hyaluronic Acid-Based Dermal Fillers Market is estimated to be USD 4.86 Bn in 2022 and is expected to reach USD 7.12 Bn by 2027, growing at a CAGR of 7.94%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Hyaluronic Acid-Based Dermal Fillers Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Hyaluronic Acid-Based Dermal Fillers Market is segmented based on Product, Application, and Geography.
  • By Product, the market is classified into Duplex Product and Single-Phase Product.
  • By Application, the market is classified into Lip Augmentation, Rhinoplasty, and Wrinkle Removal.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AbbVie Inc., Croma-Pharma GmbH, Galderma Laboratories L.P., Genzyme Corp., HUGEL, Inc., Medytox, Inc., Sinclair Pharma, Teoxane SA, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Hyaluronic Acid-Based Dermal Fillers Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Hyaluronic Acid-Based Dermal Fillers Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Hyaluronic Acid-Based Dermal Fillers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Hyaluronic Acid-Based Dermal Fillers Market

What is the estimated value of the Global Hyaluronic Acid-Based Dermal Fillers Market?

The Global Hyaluronic Acid-Based Dermal Fillers Market was estimated to be valued at $4.86 Billion in 2022.

What is the growth rate of the Global Hyaluronic Acid-Based Dermal Fillers Market?

The growth rate of the Global Hyaluronic Acid-Based Dermal Fillers Market is 7.9%, with an estimated value of $7.12 Billion by 2027.

What is the forecasted size of the Global Hyaluronic Acid-Based Dermal Fillers Market?

The Global Hyaluronic Acid-Based Dermal Fillers Market is estimated to be worth $7.12 Billion by 2027.

Who are the key companies in the Global Hyaluronic Acid-Based Dermal Fillers Market?

Key companies in the Global Hyaluronic Acid-Based Dermal Fillers Market include AbbVie Inc., Adoderm GmbH, Allergan Medical Corp., Anika Therapeutics, Inc., Bio Plus Co. Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp. Ltd., Bohus Biotech AB, Croma and Pharma GmbH.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Demand for Flawless Skin Through Non-Invasive Techniques
4.1.2 Rising Elderly Population Demand Antiaging Cosmetic and Aesthetic Treatments
4.1.3 Higher Preference Owing to the Properties Such as Lower Toxicity, Viscoelastic and Moisturizing Features
4.2 Restraints
4.2.1 Strict Government Regulations Govern During the Release and Marketing of These Products
4.3 Opportunities
4.3.1 Surge in Investments in Research and Development in The Introduction of New and Advanced Products
4.3.2 Emerging Awareness of Hyaluronic Acid-Based Dermal Fillers Worldwide
4.4 Challenges
4.4.1 Probable Side Effects Such as Redness, Swelling, and Bruising at The Injected Site
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Hyaluronic Acid-Based Dermal Fillers Market, By Product
6.1 Introduction
6.2 Duplex Product
6.3 Single-Phase Product
7 Global Hyaluronic Acid-Based Dermal Fillers Market, By Application
7.1 Introduction
7.2 Lip Augmentation
7.3 Rhinoplasty
7.4 Wrinkle Removal
8 Americas’ Hyaluronic Acid-Based Dermal Fillers Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Hyaluronic Acid-Based Dermal Fillers Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Hyaluronic Acid-Based Dermal Fillers Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Hyaluronic Acid-Based Dermal Fillers Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 AbbVie Inc.
13.2 Adoderm GmbH
13.3 Allergan Medical Corp.
13.4 Anika Therapeutics, Inc.
13.5 Bio Plus Co. Ltd.
13.6 Bioxis Pharmaceuticals
13.7 Bloomage Biotechnology Corp. Ltd.
13.8 Bohus Biotech AB
13.9 Croma-Pharma GmbH
13.10 Cynosure LLC
13.11 Dr. Korman Laboratories Ltd.
13.12 Galderma Laboratories L.P.
13.13 Genzyme Corp.
13.14 HUGEL, Inc.
13.15 Laboratoires Vivacy
13.16 LG Life Sciences, Ltd.
13.17 Medytox, Inc.
13.18 Merz Pharma GmbH & Co. KGaA
13.19 Sinclair Pharma
13.20 Teoxane SA
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • AbbVie Inc.
  • Adoderm GmbH
  • Allergan Medical Corp.
  • Anika Therapeutics, Inc.
  • Bio Plus Co. Ltd.
  • Bioxis Pharmaceuticals
  • Bloomage Biotechnology Corp. Ltd.
  • Bohus Biotech AB
  • Croma-Pharma GmbH
  • Cynosure LLC
  • Dr. Korman Laboratories Ltd.
  • Galderma Laboratories L.P.
  • Genzyme Corp.
  • HUGEL, Inc.
  • Laboratoires Vivacy
  • LG Life Sciences, Ltd.
  • Medytox, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Sinclair Pharma
  • Teoxane SA